EDUCATIONAL TOOL ONLY. Not legal or medical advice. Not affiliated with the VA.
← All Condition GuidesCLAIM RECON INTEL
Chronic Psychiatric Medication Use
DC 6299 | 38 CFR § 3.310; Allen v. Principi, 237 F.3d 1368 (Fed. Cir. 2001) |
Chronic Psychiatric Medication Use is rated by the U.S. Department of Veterans Affairs under DC 6299 of 38 CFR § 3.310; Allen v. Principi, 237 F.3d 1368 (Fed. Cir. 2001) across 3 severity tiers (40%+ -- Severe limitation or ankylosis / 20% -- Moderate limitation / 10% -- Mild limitation or painful motion). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303. This condition is frequently rated as secondary to Weight Gain or Diabetes Type II under 38 C.F.R. § 3.310.
OVERVIEW
Long-term use of psychotropic medications (SSRIs, SNRIs, atypical antipsychotics, mood stabilizers, benzodiazepines) prescribed to treat service-connected mental-health conditions. Documented side effects — sexual dysfunction (most SSRIs/SNRIs), metabolic syndrome and weight gain (atypical antipsychotics), tardive dyskinesia (antipsychotics), decreased bone density (chronic SSRI), and PSSD (post-SSRI sexual dysfunction) — are eligible for secondary service connection under 38 CFR § 3.310 when the underlying mental-health condition is service-connected.
RATING CRITERIA (3 LEVELS)
40%+ -- Severe limitation or ankylosis
Severe limitation of motion or ankylosis of the affected joint. Specific percentages depend on the joint and whether dominant/non-dominant.
20% -- Moderate limitation
Moderate limitation of motion with significant functional impairment. DeLuca factors may increase the effective rating.
10% -- Mild limitation or painful motion
Mild limitation of motion, or X-ray evidence of arthritis with painful motion under DC 5003.
KEY EVIDENCE TO GATHER
-Service treatment records showing injury or complaints
-Imaging (X-ray, MRI, CT)
-Range of motion measurements
-Flare-up documentation per Sharp v. Shulkin
-Buddy statements describing limitations
-Prescription history
-Physical therapy records
-Employment impact documentation
SECONDARY CONDITIONS (7 MAPPED)
DC
Many psychiatric medications cause metabolic changes and appetite increase
DC
Antipsychotics and some antidepressants cause insulin resistance
DC
Psychiatric medications affect lipids, glucose, and weight
DC
Antipsychotics increase triglycerides and LDL
DC
SSRIs and other psychiatric meds affect sexual function
DC
Long-term antipsychotic use causes involuntary movements
DC
Many psychiatric meds affect cardiac rhythm
C&P EXAM TIPS (6)
1.Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.
2.Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.
3.Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.
4.Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).
5.If you use assistive devices (brace, cane), bring them.
6.Describe daily activity impact: work, sleep, household tasks.
SOURCES & EDITORIAL
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.
EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026